Reed International PLC
27 February 2001
TO: COMPANY ANNOUNCEMENTS OFFICE
ISSUED ON BEHALF OF REED INTERNATIONAL P.L.C. AND ELSEVIER NV
We are writing to advise you that we have today received notification of the
following transactions in the ordinary shares of Reed International P.L.C. and
Elsevier NV:
1. C H L Davis, a director of Reed International P.L.C. and Elsevier NV,
purchased today 29,293 Reed International P.L.C. ordinary shares at 676.984p
per share and 20,854 Elsevier NV ordinary shares at EUR 15.095 per share.
Following this purchase, Mr Davis now holds 74,071 ordinary shares in Reed
International P.L.C. and 51,953 ordinary shares in Elsevier NV.
2. A Prozes, a director of Reed International P.L.C., purchased 3,040 American
Depositary Shares in Reed International P.L.C. at US$39.3503 per ADS on 23
February 2001 and 2,750 American Depositary Shares in Reed International
P.L.C. at US$38.6496 per ADS on 26 February 2001.
In addition, Mr Prozes purchased 3,625 American Depositary Shares in
Elsevier NV at US$26.8845 on 23 February 2001.
Each Reed International ADS represents four Reed International ordinary
shares and each Elsevier ADS represents two Elsevier ordinary shares. As a
consequence, Mr Prozes holds an interest in 23,160 Reed International
ordinary shares and 7,250 Elsevier ordinary shares.
ISSUED ON BEHALF OF REED INTERNATIONAL P.L.C. AND ELSEVIER NV
We are writing to advise you that we received notification yesterday of the
following transactions in Reed International P.L.C. and Elsevier NV ordinary
shares.
The following grants have been made to directors of Reed International P.L.C.
and Elsevier NV, under the Reed Elsevier plc Executive Share Option Scheme:
Date of Director No. of Reed No. of Elsevier Exercisable
Grant International shares over
shares over which an option
which an has been granted
option has at EUR 14.75 per
been granted share
at 659p per
share
23.2.2001 C H L Davis 122,914 87,601 2004-2011
23.2.2001 M H Armour 62,974 44,882 2004-2011
23.2.2001 D J Haank 51,110 36,426 2004-2011
The following grants have made to directors of Reed International P.L.C., under
the terms of the Reed Elsevier plc Executive Share Option Scheme:
Date of Director No. of Reed No. of Elsevier Exercisable
Grant International shares over
shares over which an option
which an has been granted
option has at EUR 14.75 per
been granted share
at 659p per
share
23.2.2001 A Prozes 83,785 59,714 2004-2011
23.2.2001 G J A van de 49,317 35,148 2004-2011
Aast
Exercise of the above options is subject to the earnings per share performance
conditions, as described in the company's Annual Financial Statements.
FROM: L DIXON
FOR AND ON BEHALF OF REED ELSEVIER PLC
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.